Dr. Ofobuike Okani is an expert in the field of Oncology. He graduated from University of Texas Southwestern Medical School. He received 1 awards: "Meaningful Use Stage 1 Certification". Dr. Ofobuike Okani is a published doctor. He has 3 publications published. The most current publication "Seven-week continuous-infusion paclitaxel with concurrent radiotherapy for locally advanced head and neck squamous cell cancer: a phase I study." Ofobuike Okani, MD is registered with Medicare.
NPI NUMBER | 1821104431 | |
NPPES Provider LastName | OKANI | |
NPPES Provider FirstName | OFOBUIKE | |
NPPES Provider ZIPCode | 767126985 | |
NPPES Provider State | TX | |
Specialty Description | Hematology/Oncology | |
Total Claim Count | 951.0 | |
Distinct Opioid Count | 1.0 | |
Opioid Claim Count | 48.0 | |
Percent Opioid Claims | 5.05 |
National Provider Identifier [NPI] | 1821104431 |
Last Name Of The Provider | OKANI |
First Name Of The Provider | OFOBUIKE |
View All |
![]() |
Dr. Baochong B. Chang, MD
![]() |
![]() |
Dr. Sara M. Conde, MD
![]() |
![]() |
Dr. Carl G. Chakmakjian, MD
![]() |
![]() |
Dr. Carlos A. Encarnacion, MD
![]() |
![]() |
Dr. Lawrence C. Canning, MD
![]() |
![]() |
Dr. Robert L. Anderson, MD
![]() |
![]() |
Dr. Sara M. Conde, MD |